Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10051913HBVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30007496HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30007497HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30048625HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30020480HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30017649HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS20027059HPVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS44005691HTLV-1ENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS44013933HTLV-1ENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS44024002HTLV-1ENSG00000196218.15protein_codingRYR1NoNo6261P21817
TCGA Plot Options
Drug Information
GeneRYR1
DrugBank IDDB00201
Drug NameCaffeine
Target IDBE0000739
UniProt IDP21817
Regulation Type
PubMed IDs17514358
CitationsDaly JW: Caffeine analogs: biomedical impact. Cell Mol Life Sci. 2007 Aug;64(16):2153-69.
GroupsApproved
Direct ClassificationXanthines
SMILESCN1C=NC2=C1C(=O)N(C)C(=O)N2C
PathwaysCaffeine Metabolism
PharmGKBPA448710
ChEMBLCHEMBL113